Combivit Solution for Injection

국가: 영국

언어: 영어

출처: VMD (Veterinary Medicines Directorate)

유효 성분:

Ascorbic Acid, Nicotinamide, Pyridoxine Hydrochloride, Riboflavine Sodium Phosphate, Thiamine Hydrochloride

제공처:

Norbrook Laboratories Limited

ATC 코드:

QA11EB

INN (국제 이름):

Ascorbic Acid, Nicotinamide, Pyridoxine Hydrochloride, Riboflavine Sodium Phosphate, Thiamine Hydrochloride

약제 형태:

Solution for injection

처방전 유형:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

치료 그룹:

Cattle, Horses, Sheep

치료 영역:

Vitamin

승인 상태:

Expired

승인 날짜:

1993-12-21

제품 특성 요약

Revised 29 October 2008
AN: 00761/2008
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Combivit Solution for Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Thiamine Hydrochloride
3.50 % w/v
Riboflavin Sodium Phosphate
0.05 % w/v
Pyridoxine Hydrochloride
0.70 % w/v
Nicotinamide
2.30 % w/v
Ascorbic Acid
7.0 % w/v
EXCIPIENTS:
Chlorocresol (as preservative)
0.1 % w/v
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Solution for injection.
A clear, pale yellow liquid, free from visible particles.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses
Cattle
Sheep
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of cerebrocortical necrosis in cattle and sheep, the
treatment of bracken poisoning in horses and for the treatment of
Vitamin
B deficiencies in horses, cattle and sheep.
Revised 29 October 2008
AN: 00761/2008
4.3
CONTRA-INDICATIONS
Anaphylactic reactions, particularly in the horse, may occur following
intravenous administration. When this route is used, the product
should
be given slowly and may be diluted with sterile saline or dextrose
saline
solution.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None known.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
Care should be taken to avoid accidental self-injection.
Wash hands after use.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
There may be slight irritation at the injection site when the product
is given
by the subcutaneous or intramuscular routes.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Combivit can be safely administered to pregnant and lactating animals.
4.8
INTERACTION
WITH
OTHER
MEDICINAL
PRODUCTS
AND
OTHER
FORMS
OF
INTERACTION
None known.
Revised 29 October 2008
AN: 00761/2008
4.9
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
Administer by subcutaneous, deep intramuscular or slow intravenous
injection. The dose sh